Product Highlight - Briviact

27 Sep 2019
Product Highlight - Briviact
“Remove the wait, and see what BRIVIACT can do for Epilepsy patients…”
• Therapeutic dose from day 11
• Demonstrated significant efficacy without up-titration2,3
• Available in multiple bioequivalent formulations1
• A new molecule from a trusted Racetam class

References:
1. BRIVIACT Hong Kong Prescribing information.
2. Adjunctive Brivaracetam in adults with uncontrolled focal epilepsy. Epilepsia; 2014; 55;1;47-56.
3. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults. Epilepsia; 2014;55;1;57-66.

UCB PHARMA (HONG KONG) LTD.

21/F, Cityplaza Three, 14 Taikoo Wan Rd, Taikoo, Hong Kong
Tel: (+852) 2854 9333 • Fax: (+852) 2854 9111

Related MIMS Drugs